Skip to main content
Equibles

SR One Capital Management, LP

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1910264 Redwood City, CA
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$4,599,572
+$1,713,647 QoQ
Shares Held
137,753
0.0% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#93
of 311 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SR One Capital Management, LP holds $1,012,394,333 across 14 Biotechnology names. RARE ranks #13 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MANE
Veradermics, Inc
 2,401,868 $295,285,651
2 ZBIO
Zenas BioPharma, Inc.
 5,037,854 $127,860,734
3 CRSP
CRISPR Therapeutics AG
 2,038,763 $111,194,134
4 AVLN
Avalyn Pharma Inc.
 3,308,649 $108,920,725
5 DSGN
Design Therapeutics, Inc.
 6,526,476 $94,438,107
6 ODTX
Odyssey Therapeutics, Inc.
 3,794,883 $71,002,260
7 ALMS
Alumis Inc.
 1,959,896 $55,151,473
8 ORIC
Oric Pharmaceuticals, Inc.
 4,615,384 $49,984,608

All Filings in RARE

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,599,572 137,753
2026-03-31 $2,885,925 137,753
2025-12-31 $3,168,319 137,753